Business News

Scientists say they have solved the mystery of the blood vaccine Covid


Scientists in Germany are said to have disrupted the blood-borne pathogens of Oxford / AstraZeneca and Johnson & Johnson vaccines and believe the jabs could be modified to control the effects.

Rolf Marschalek, a professor at Goethe University in Frankfurt who has been leading research into the crisis since March, said his research showed that the problem had adenovirus vectors that both vaccines use to deliver the Sars-Cov-2 protein virus. .

Reproductive system means that the vaccine sends a sweet protein inside the cell instead of the cytosol fluid found inside the skin where the virus produces the protein, Marschalek and other scientists have said. Printed papers were released Wednesday.

Once inside the skin, certain parts of the spike protein splice, or division, form a reversible form, which is unable to connect to the cell membrane where the required vaccine is needed. Moveable floating proteins are released by cells in the body, causing the blood to clot in about one in 100,000 people, according to Marschalek.

In contrast, mRNA vaccines, such as BioNTech / Pfizer and Moderna jabs, send spike organisms into the gastrointestinal tract and do not penetrate.

“When these. . . the virus genes within them can cause other problems, “Marschalek told the Financial Times.

Recent blood transfusions that have disrupted AstraZeneca and J&J shootings have been recorded in 309 of the 33m people who have received AstraZeneca vaccine in the UK, killing 56 people.

In response, the use of the AstraZeneca jab has been banned or suspended in more than a dozen countries. J&J began launching its vaccine in Europe with a written warning in April a little late due to concerns.

But Marschalek believes there is a straightforward way for vaccinators to change their proteins.

J&J had already contacted the Marschalek lab for guidance and was looking for ways to change its vaccine to prevent twisting, he said.

The sweet proteins in the J&J shot were previously less prone to “pumping” than the sweet proteins in the AstraZeneca shell, which makes the reaction less common, according to Marschalek. In the US, eight of the 7.4 million recipients of the J&J rifle say no.

“[J&J] he is trying to improve his vaccine now, ”he said. “We have the information we have in our hands to tell companies how to change this, and to write proteins in a way that prevents unplanned responses.”

Marschalek said his lab had not yet discussed his findings with AstraZeneca. “[AstraZeneca] They have not contacted us so we have not spoken to them, but if they do I can tell them what to do to make a good vaccine, ”he said.

J&J said: “We are helping to further investigate and evaluate these needs as we work with medical professionals and health care providers around the world. We look forward to reviewing and sharing the information.”

AstraZeneca did not immediately respond to a request for comment.

Some scientists have warned that Marschalek’s theory is one of many, and that further evidence is needed to prove it.

“There is a lack of evidence to support the house chain. . . of a protein called spike in the occurrence of thrombosis, “says Johannes Oldenburg, a professor of hematology at the University of Bonn.”

Marschalek will donate the lab to the Paul-Ehrlich Institute of Germany and the National Vaccination Agency.

“They were surprised by what we found, because no one cares about the splice problem,” he said.


Source link

Related Articles

Leave a Reply

Back to top button